Aberrant expression of GATA binding protein 6 correlates with poor prognosis and promotes metastasis in cholangiocarcinoma

European Journal of Cancer

Volumn 49, Issue 7, 2013, Pages 1771-1780

  Tian, Feng ^a   Li, Dajiang ^a   Chen, Jian ^a   Liu, Wei ^a   Cai, Lei ^a   Li, Jianwei ^a   Jiang, Peng ^a   Liu, Zipei ^a   Zhao, Xin ^a   Guo, Fei ^a   Li, Xiaowu ^a   Wang, Shuguang ^a  

^a THIRD MILITARY MEDICAL UNIVERSITY   (China)

Author keywords

67 kDa laminin receptor; Cholangiocarcinoma; GATA6; Metastasis; Prognosis

Indexed keywords

LAMININ RECEPTOR; MESSENGER RNA; SHORT HAIRPIN RNA; TRANSCRIPTION FACTOR GATA 6;

ADULT; ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; BILE DUCT CARCINOMA; CANCER INVASION; CANCER PROGNOSIS; CANCER RECURRENCE; CELL MIGRATION; CHROMATIN IMMUNOPRECIPITATION; CONTROLLED STUDY; FEMALE; HUMAN; HUMAN CELL; IMMUNOHISTOCHEMISTRY; IN VITRO STUDY; LENTIVIRINAE; LIVER METASTASIS; LYMPH NODE METASTASIS; MAJOR CLINICAL STUDY; MALE; METASTASIS; MOUSE; NONHUMAN; NUCLEOTIDE SEQUENCE; OVERALL SURVIVAL; PRIMARY TUMOR; PRIORITY JOURNAL; PROMOTER REGION; PROTEIN EXPRESSION; RECURRENCE FREE SURVIVAL; XENOTRANSPLANTATION;

AGED; ANIMALS; BILE DUCT NEOPLASMS; BILE DUCTS, INTRAHEPATIC; BLOTTING, WESTERN; CELL LINE, TUMOR; CELL MOVEMENT; CHOLANGIOCARCINOMA; FEMALE; GATA6 TRANSCRIPTION FACTOR; HUMANS; IMMUNOHISTOCHEMISTRY; KAPLAN-MEIER ESTIMATE; LYMPHATIC METASTASIS; MALE; MICE; MICE, NUDE; MIDDLE AGED; PROGNOSIS; PROMOTER REGIONS, GENETIC; PROPORTIONAL HAZARDS MODELS; PROTEIN BINDING; RECEPTORS, LAMININ; REVERSE TRANSCRIPTASE POLYMERASE CHAIN REACTION; RIBOSOMAL PROTEINS; RNA INTERFERENCE; TRANSPLANTATION, HETEROLOGOUS;

EID: 84876100554     PISSN: 09598049     EISSN: 18790852     Source Type: Journal    
DOI: 10.1016/j.ejca.2012.12.015     Document Type: Article

References (34)

1. B. Blechacz, and G.J. Gores Cholangiocarcinoma: advances in pathogenesis, diagnosis, and treatment Hepatology 48 2008 308 321 (Pubitemid 351975555)
2. I. Endo, M. Gonen, and A.C. Yopp Intrahepatic cholangiocarcinoma: rising frequency, improved survival, and determinants of outcome after resection Ann Surg 248 2008 84 96
3. F. Ito, C.S. Cho, L.F. Rikkers, and S.M. Weber Hilar cholangiocarcinoma: current management Ann Surg 250 2009 210 218
4. N.A. van der Gaag, J.J. Kloek, and J.K. de Bakker Survival analysis and prognostic nomogram for patients undergoing resection of extrahepatic cholangiocarcinoma Ann Oncol 23 2012 2642 2649
5. R.K. Patient, and J.D. McGhee The GATA family (vertebrates and invertebrates) Curr Opin Genet Dev 12 2002 416 422 (Pubitemid 34722920)
6. J.B. Burch Regulation of GATA gene expression during vertebrate development Semin Cell Dev Biol 16 2005 71 81 (Pubitemid 40126878)
7. F. Ayanbule, N.S. Belaguli, and D.H. Berger GATA factors in gastrointestinal malignancy World J Surg 35 2011 1757 1765
8. N.S. Belaguli, M. Aftab, and M. Rigi GATA6 promotes colon cancer cell invasion by regulating urokinase plasminogen activator gene expression Neoplasia 12 2010 856 865
9. K.A. Kwei, M.D. Bashyam, and J. Kao Genomic profiling identifies GATA6 as a candidate oncogene amplified in pancreatobiliary cancer PLoS Genet 4 2008 e1000081
10. Y. Zhong, Z. Wang, and B. Fu GATA6 activates Wnt signaling in pancreatic cancer by negatively regulating the Wnt antagonist dickkopf-1 PLoS One 6 2011 e22129
11. L. Lin, A.J. Bass, and W.W. Lockwood Activation of GATA binding protein 6 (GATA6) sustains oncogenic lineage-survival in esophageal adenocarcinoma Proc Natl Acad Sci USA 109 2012 4251 4256
12. C.D. Capo-chichi, I.H. Roland, and L. Vanderveer Anomalous expression of epithelial differentiation-determining GATA factors in ovarian tumorigenesis Cancer Res 63 2003 4967 4977 (Pubitemid 37022633)
13. D. Kamnasaran, B. Qian, and C. Hawkins GATA6 is an astrocytoma tumor suppressor gene identified by gene trapping of mouse glioma model Proc Natl Acad Sci USA 104 2007 8053 8058 (Pubitemid 47185874)
14. J.D. Molkentin The zinc finger-containing transcription factors GATA-4, -5, and -6. Ubiquitously expressed regulators of tissue-specific gene expression J Biol Chem 275 2000 38949 38952 (Pubitemid 32058903)
15. M. Maeda, K. Ohashi, and A. Ohashi-Kobayashi Further extension of mammalian GATA-6 Dev Growth Differ 47 2005 591 600 (Pubitemid 43151675)
16. E. Beuling, N.Y. Baffour-Awuah, and K.A. Stapleton GATA factors regulate proliferation, differentiation, and gene expression in small intestine of mature mice Gastroenterology 140 2011 1219 1229 e1-2
17. V. Givant-Horwitz, B. Davidson, and R. Reich Laminin-induced signaling in tumor cells Cancer Lett 223 2005 1 10 (Pubitemid 40693705)
18. J. Nelson, N.V. McFerran, and G. Pivato The 67 kDa laminin receptor: structure, function and role in disease Biosci Rep 28 2008 33 48
19. D. Li, J. Chen, and Z. Gao 67-kDa laminin receptor in human bile duct carcinoma Eur Surg Res 42 2009 168 173
20. S.G. Duan, L. Cheng, and D.J. Li The role of MAPK-ERK pathway in 67-kDa laminin receptor-induced FasL expression in human cholangiocarcinoma cells Dig Dis Sci 55 2010 2844 2852
21. L. Liu, L. Sun, and P. Zhao Hypoxia promotes metastasis in human gastric cancer by up-regulating the 67-kDa laminin receptor Cancer Sci 101 2010 1653 1660
22. F. Tian, L. Cheng, and D. Li Downregulation of mucins in graft bile ducts after liver transplantation in rats Transplantation 92 2011 529 535
23. Q. He, L. Cai, and L. Shuai Ars2 is overexpressed in human cholangiocarcinomas and its depletion increases PTEN and PDCD4 by decreasing MicroRNA-21 Mol Carcinog 2011 Epub ahead of print
24. L. Fabris, M. Cadamuro, and L. Moserle Nuclear expression of S100A4 calcium binding protein increases cholangiocarcinoma invasiveness and metastasization Hepatology 54 2011 890 899
25. A. Saxena, T.C. Chua, and F.C. Chu Improved outcomes after aggressive surgical resection of hilar cholangiocarcinoma: a critical analysis of recurrence and survival Am J Surg 202 2011 310 320
26. A. Saxena, T.C. Chua, and A. Sarkar Clinicopathologic and treatment-related factors influencing recurrence and survival after hepatic resection of intrahepatic cholangiocarcinoma: a 19-year experience from an established Australian hepatobiliary unit J Gastrointest Surg 14 2010 1128 1138
27. E. Hidalgo, S. Asthana, and H. Nishio Surgery for hilar cholangiocarcinoma: the Leeds experience Eur J Surg Oncol 34 2008 787 794 (Pubitemid 351814991)
28. S. Jonas, A. Thelen, and C. Benckert Extended liver resection for intrahepatic cholangiocarcinoma: a comparison of the prognostic accuracy of the fifth and sixth editions of the TNM classification Ann Surg 249 2009 303 309
29. M.C. de Jong, H. Nathan, and G.C. Sotiropoulos Intrahepatic cholangiocarcinoma: an international multi-institutional analysis of prognostic factors and lymph node assessment J Clin Oncol 29 2011 3140 3145
30. Y.C. Huang, M. Chen, and Y.M. Shyr Glycine N-methyltransferase is a favorable prognostic marker for human cholangiocarcinoma J Gastroenterol Hepatol 23 2008 1384 1389
31. I. Vande Broek, K. Vanderkerken, and C. De Greef Laminin-1-induced migration of multiple myeloma cells involves the high-affinity 67 kD laminin receptor Br J Cancer 85 2001 1387 1395 (Pubitemid 33081937)
32. V. Givant-Horwitz, B. Davidson, and R. Reich Laminin-induced signaling in tumor cells: the role of the M(r) 67,000 laminin receptor Cancer Res 64 2004 3572 3579 (Pubitemid 38657934)
33. P. Thummarati, S. Wijitburaphat, and A. Prasopthum High level of urokinase plasminogen activator contributes to cholangiocarcinoma invasion and metastasis World J Gastroenterol 18 2012 244 250
34. R. Fang, L.C. Olds, and N.A. Santiago GATA family transcription factors activate lactase gene promoter in intestinal Caco-2 cells Am J Physiol Gastrointest Liver Physiol 280 2001 G58 G67